MDCXW Medicus Pharma Ltd. Warrant
$0.33▲ +0.00%
Healthcare
Other
Volume 92
Avg Volume (10D) 0
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.24 - 2.50
% vs 50 MA
-54.35%
% vs 200 MA
-84.55%
RSI-14
43.2
MACD Histogram
+0.0000
Beta (1Y vs SPY)
-0.58
Free Cash Flow
-$6.98M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$11.48M
COGS
–
Operating Exp
$11.48M
Operating Income
-$11.48M
EBIT
-$11.48M
Pretax Income
-$11.68M
Net Income
-$11.62M
Price & Volume History
Loading chart…
Recent News
Medicus Pharma CEO to present precision oncology progress at global biotech conferences
Proactive · Oct 27, 2026 9:26 AM ET
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
GlobeNewswire · Oct 27, 2026 7:30 AM ET
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire · Oct 26, 2026 7:30 AM ET
Medicus Pharma Outlines Clinical Development Strategy Across Three Drug Programs Following $90 Million in Financing
InvestorsHub · Oct 8, 2026 10:41 AM ET
Medicus Pharma targets partnerships and clinical milestones as oncology pipeline advances
Proactive · Oct 8, 2026 9:04 AM ET
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
GlobeNewswire · Oct 8, 2026 8:00 AM ET
Medicus Pharma files streamlined Phase 2b/3 prostate cancer trial design with FDA
Proactive · Sep 29, 2026 8:59 AM ET
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
GlobeNewswire · Sep 29, 2026 7:30 AM ET
Medicus Pharma to focus SkinJect development exclusively on Gorlin syndrome patients
Proactive · Sep 21, 2026 9:50 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MDCXW's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.